SRIKANTH ARANI REDDY M.D.
NPI 1649440744
Internal Medicine - Hematology & Oncology in Antioch, CA

Active since March 04, 2008PECOS EnrolledAccepts Medicare Assignment
4721 DALLAS RANCH RD, ANTIOCH, CA 94531(925) 778-0679(925) 778-3567 Get Directions Write a Review

NPPES record last updated: May 23, 2023. Verified against the NPPES registry weekly; last sync: July 26, 2026.

About Srikanth Arani Reddy M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

SRIKANTH ARANI REDDY M.D. (NPI 1649440744) is an individual hematology & oncology provider in Antioch, California, licensed in California (A99810) and active in the NPI registry since March 2008. He is enrolled in Medicare PECOS and is a graduate of Albany Medical College Of Union University (2005).

NPPES Registry Identity

NPI1649440744
Entity TypeIndividualMale
Primary Taxonomy207RH0003X
Provider Legal NameSRIKANTH ARANI REDDYCredential: M.D.
Location Address4721 DALLAS RANCH RDAntioch, CA 94531-8811
Mailing Address4721 Dallas Ranch RdAntioch, CA 94531-8811 · (925) 778-0679 · Fax (925) 778-3567
Fax(925) 778-3567
Sole ProprietorNo
Medical School CMSAlbany Medical College Of Union UniversityGraduated 2005
Enumeration DateMarch 4, 2008
Last NPPES UpdateMay 23, 2023
NPPES CertifiedMay 23, 2023
NPI 1649440744 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyInternal Medicine · Hematology & OncologyAllopathic & Osteopathic Physicians
Taxonomy Code207RH0003X
License Licensed in CA · A99810
Definition

An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.

Also ListedInternal MedicineTaxonomy 207R00000X · License A99810 (CA)
4721 DALLAS RANCH RD, Antioch, CA 94531

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Srikanth Arani Reddy M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID9830360932
PECOS Enrollment IDI20110921000690
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 39

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
9,900 services79 patients
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units Q5106
Epoetin alfa-epbx (Retacrit) is a biosimilar injection used for non-ESRD (End-Stage Renal Disease). It helps your body make more red blood cells, increasing your energy and well-being. It's usually given under the skin or into a vein by a healthcare professional.
5,070 services20 patients
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967
Low osmolar contrast material with 300-399 mg/ml iodine concentration is a diagnostic tool used in imaging procedures. It helps to enhance the visibility of specific areas in the body, aiding in accurate diagnosis. It's safe and generally well-tolerated by patients.
4,400 services40 patients
Injection, gadobutrol, 0.1 ml A9585
Gadobutrol is a contrast agent used during MRI scans to help provide clearer images. It's injected into your vein before the scan. This helps doctors to see certain areas more clearly for better diagnosis. It's generally safe with few side effects.
2,525 services23 patients
Insertion of needle into vein for collection of blood sample 36415
This procedure involves inserting a small needle into a vein, typically in your arm, to collect a blood sample. It's a quick and simple process to help diagnose or monitor health conditions. You may feel a small prick, but discomfort is minimal.
1,068 services301 patients
Injection, dexamethasone sodium phosphate, 1 mg J1100
Dexamethasone sodium phosphate is a medication given via injection. It is a type of steroid that helps reduce inflammation and immune responses. It can be used to treat a variety of conditions, such as allergies, skin conditions, arthritis, and more.
870 services16 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 94531 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$202.35 typical visit price
range $69.00 – $202.35
Typical copayment $50.58 (range $17.25 – $50.58)
Most-billed visit code 99205
Established Patient
$119.48 typical visit price
range $23.44 – $166.46
Typical copayment $29.87 (range $5.86 – $41.61)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

Reported Quality Measures

Breast Cancer Screening
Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer
10%154 patients1/55-star benchmark: 92%
Cervical Cancer Screening
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria: - Women age 21-64 who had cervical cytology performed every 3 years - Women age 30-64 who had cervical cytology/human papillomavirus (HPV)…
1%148 patients
Closing the Referral Loop: Receipt of Specialist Report
Percentage of patients with referrals, regardless of age, for which the referring provider receives a report from the provider to whom the patient was referred
1%162 patients1/55-star benchmark: 95%
Colorectal Cancer Screening
Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer
16%270 patients1/55-star benchmark: 85%
Diabetes: Medical Attention for Nephropathy
The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period
75%67 patients4/55-star benchmark: 99%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
95%1,661 patients4/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
95%1,164 patients4/55-star benchmark: 99%
Falls: Screening for Future Fall Risk
Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period
1%273 patients1/55-star benchmark: 99%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
97%1,527 patients4/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
91%535 patients4/55-star benchmark: 97%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
14%273 patients1/55-star benchmark: 90%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous…
72%527 patients3/55-star benchmark: 97%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
13%252 patients1/55-star benchmark: 88%
Preventive Care and Screening: Screening for Depression and Follow-Up Plan
Percentage of patients aged 12 years and older screened for depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen
2%496 patients1/55-star benchmark: 96%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
Patients tobacco: 72% · 352 patients
83%352 patients
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
82%535 patients4/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
3%535 patients1/55-star benchmark: 89%
Use of High-Risk Medications in the Elderly
Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication.
Lower rates are better for this measure.
Patients 2+: 5% · 273 patients
8%273 patients3/55-star benchmark: 100%
View, Download, or Transmit (VDT)
At least one patient seen by the MIPS eligible clinician during the performance period (or patient-authorized representative) views, downloads or transmits their health information to a third party during the performance period.
11%535 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Referred Medical Equipment & Supplies CMS DME claims 4

Durable medical equipment, devices and supplies this provider ordered from DME suppliers for patients, from Medicare fee-for-service claims.

Capecitabine, oral, 500 mg J8521
Treatment-Treatment - Miscellaneous · category RX029N
2 suppliers37 claims2,716 services$0.72 avg. paid by Medicare
Temozolomide, oral, 5 mg J8700
Treatment-Treatment - Miscellaneous · category RX000N
2 suppliers11 claims3,332 services$0.26 avg. paid by Medicare
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period Q0511
Treatment-Chemotherapy · category RH012N
2 suppliers24 claims24 services$18.19 avg. paid by Medicare
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period Q0512
Treatment-Chemotherapy · category RH012N
2 suppliers26 claims29 services$12.65 avg. paid by Medicare
Dollar amounts are the average Medicare paid the supplier per service. They are not the cost to the patient.

Other Providers at the Same Location NPPES 15

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Internal Medicine (Hematology & Oncology)
4721 DALLAS RANCH RD
ANTIOCH, CA 94531
Hospice Care, Community Based
4721 DALLAS RANCH RD
ANTIOCH, CA 94531
Radiology (Radiation Oncology)
4721 DALLAS RANCH RD
ANTIOCH, CA 94531
Internal Medicine (Hematology & Oncology)
4721 DALLAS RANCH RD
ANTIOCH, CA 94531
Internal Medicine (Hematology & Oncology)
4721 DALLAS RANCH RD
ANTIOCH, CA 94531
Radiology (Radiation Oncology)
4721 DALLAS RANCH RD
ANTIOCH, CA 94531
Internal Medicine (Hematology & Oncology)
4721 DALLAS RANCH RD
ANTIOCH, CA 94531
Internal Medicine (Hematology & Oncology)
4721 DALLAS RANCH RD
ANTIOCH, CA 94531

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Srikanth Reddy's NPI number?

The NPI number for Srikanth Reddy is 1649440744. It was assigned to this individual provider in the NPPES registry on March 4, 2008.

Where is Srikanth Reddy located?

Srikanth Reddy practices at 4721 Dallas Ranch Rd, Antioch, CA 94531. The listed phone number is (925) 778-0679.

What is Srikanth Reddy's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Hematology & Oncology, with taxonomy code 207RH0003X.

Is Srikanth Reddy enrolled in Medicare?

Yes. Srikanth Reddy is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Srikanth Reddy was last updated on May 23, 2023. NPI Profile syncs with the weekly NPPES data releases published by CMS.